Literature DB >> 12847235

Immune modulation by silencing IL-12 production in dendritic cells using small interfering RNA.

Jonathan A Hill1, Thomas E Ichim, Kornel P Kusznieruk, Mu Li, Xuyan Huang, Xiaotao Yan, Robert Zhong, Ewa Cairns, David A Bell, Wei-Ping Min.   

Abstract

RNA interference is a mechanism of posttranscriptional gene silencing that functions in most eukaryotic cells, including human and mouse. Specific gene silencing is mediated by short strands of duplex RNA of approximately 21 nt in length (termed small interfering RNA or siRNA) that target the cognate mRNA sequence for degradation. We demonstrate here that RNAi can be used for immune modulation by targeting dendritic cell (DC) gene expression. Transfection of DC with siRNA specific for the IL-12 p35 gene resulted in potent suppression of gene expression and blockade of bioactive IL-12 p70 production without affecting unrelated genes or cellular viability. Inhibition of IL-12 was associated with increased IL-10 production, which endowed the DC with the ability to stimulate production of Th2 cytokines from allogenic T cells in vitro. Furthermore, siRNA-silenced DC lacking IL-12 production were poor allostimulators in MLR. IL-12-silenced and KLH-pulsed DC polarized the immune response toward a Th2 cytokine profile in an Ag-specific manner. These data are the first to demonstrate that RNA interference is a potent and specific tool for modulating DC-mediated immune responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12847235     DOI: 10.4049/jimmunol.171.2.691

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  27 in total

1.  A novel approach for evaluating the efficiency of siRNAs on protein levels in cultured cells.

Authors:  Weilin Wu; Emily Hodges; Jenny Redelius; Christer Höög
Journal:  Nucleic Acids Res       Date:  2004-01-22       Impact factor: 16.971

Review 2.  Tracking dendritic cells in vivo: insights into DC biology and function.

Authors:  Huiming Hon; Joshy Jacob
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 3.  Tolerogenic dendritic cells and their potential applications.

Authors:  Jim Hu; Yonghong Wan
Journal:  Immunology       Date:  2011-01-05       Impact factor: 7.397

Review 4.  RNA interference in biology and disease.

Authors:  Carol A Sledz; Bryan R G Williams
Journal:  Blood       Date:  2005-04-12       Impact factor: 22.113

Review 5.  Advancements in immune tolerance.

Authors:  Ping-Ying Pan; Junko Ozao; Zuping Zhou; Shu-Hsia Chen
Journal:  Adv Drug Deliv Rev       Date:  2007-10-05       Impact factor: 15.470

6.  Silencing of endogenous IL-10 in human dendritic cells leads to the generation of an improved CTL response against human melanoma associated antigenic epitope, MART-1 27-35.

Authors:  Arvind Chhabra; Nitya G Chakraborty; Bijay Mukherji
Journal:  Clin Immunol       Date:  2008-01-14       Impact factor: 3.969

7.  The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (alpha-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages.

Authors:  A W Taylor
Journal:  J Neuroimmunol       Date:  2005-05       Impact factor: 3.478

8.  Increased IkappaB alpha expression is essential for the tolerogenic property of TGF-beta-exposed APCs.

Authors:  Paiman Ghafoori; Takeru Yoshimura; Bruce Turpie; Sharmila Masli
Journal:  FASEB J       Date:  2009-02-23       Impact factor: 5.191

9.  Endoplasmic reticulum stress-mediated apoptosis involved in indirect recognition pathway blockade induces long-term heart allograft survival.

Authors:  Jianbin Xiang; Xiaodong Gu; Shiguang Qian; Zongyou Chen
Journal:  J Biomed Biotechnol       Date:  2010-05-16

10.  RNAi-mediated CD40-CD154 interruption promotes tolerance in autoimmune arthritis.

Authors:  Xiufen Zheng; Motohiko Suzuki; Xusheng Zhang; Thomas E Ichim; Fei Zhu; Hong Ling; Aminah Shunnar; Michael H Wang; Bertha Garcia; Robert D Inman; Wei-Ping Min
Journal:  Arthritis Res Ther       Date:  2010-01-26       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.